nodes	percent_of_prediction	percent_of_DWPC	metapath
Xylometazoline—ADRA2C—attention deficit hyperactivity disorder	0.432	0.524	CbGaD
Xylometazoline—HTR1B—attention deficit hyperactivity disorder	0.208	0.252	CbGaD
Xylometazoline—ADRA2A—attention deficit hyperactivity disorder	0.184	0.224	CbGaD
Xylometazoline—Oxymetazoline—ADRA2C—attention deficit hyperactivity disorder	0.00323	0.463	CrCbGaD
Xylometazoline—Oxymetazoline—HTR1B—attention deficit hyperactivity disorder	0.00156	0.223	CrCbGaD
Xylometazoline—ADRA1D—forebrain—attention deficit hyperactivity disorder	0.00148	0.0653	CbGeAlD
Xylometazoline—Oxymetazoline—ADRA2A—attention deficit hyperactivity disorder	0.00138	0.198	CrCbGaD
Xylometazoline—HTR1B—forebrain—attention deficit hyperactivity disorder	0.00115	0.0505	CbGeAlD
Xylometazoline—HTR1D—forebrain—attention deficit hyperactivity disorder	0.00111	0.0488	CbGeAlD
Xylometazoline—HTR1B—cardiovascular system—attention deficit hyperactivity disorder	0.000969	0.0427	CbGeAlD
Xylometazoline—HTR1D—cardiovascular system—attention deficit hyperactivity disorder	0.000938	0.0413	CbGeAlD
Xylometazoline—ADRA1A—forebrain—attention deficit hyperactivity disorder	0.000852	0.0375	CbGeAlD
Xylometazoline—ADRA1B—nervous system—attention deficit hyperactivity disorder	0.000823	0.0363	CbGeAlD
Xylometazoline—Oxymetazoline—HTR2A—attention deficit hyperactivity disorder	0.000808	0.116	CrCbGaD
Xylometazoline—ADRA1D—nervous system—attention deficit hyperactivity disorder	0.000805	0.0355	CbGeAlD
Xylometazoline—ADRA1B—central nervous system—attention deficit hyperactivity disorder	0.000793	0.0349	CbGeAlD
Xylometazoline—ADRA1D—central nervous system—attention deficit hyperactivity disorder	0.000775	0.0342	CbGeAlD
Xylometazoline—HTR1B—midbrain—attention deficit hyperactivity disorder	0.000756	0.0333	CbGeAlD
Xylometazoline—HTR1D—midbrain—attention deficit hyperactivity disorder	0.000732	0.0323	CbGeAlD
Xylometazoline—ADRA1A—cardiovascular system—attention deficit hyperactivity disorder	0.000721	0.0317	CbGeAlD
Xylometazoline—ADRA2A—forebrain—attention deficit hyperactivity disorder	0.000648	0.0285	CbGeAlD
Xylometazoline—ADRA1B—brain—attention deficit hyperactivity disorder	0.000629	0.0277	CbGeAlD
Xylometazoline—HTR1B—nervous system—attention deficit hyperactivity disorder	0.000622	0.0274	CbGeAlD
Xylometazoline—ADRA1D—brain—attention deficit hyperactivity disorder	0.000616	0.0271	CbGeAlD
Xylometazoline—HTR1D—nervous system—attention deficit hyperactivity disorder	0.000602	0.0265	CbGeAlD
Xylometazoline—HTR1B—central nervous system—attention deficit hyperactivity disorder	0.000599	0.0264	CbGeAlD
Xylometazoline—HTR1D—central nervous system—attention deficit hyperactivity disorder	0.00058	0.0255	CbGeAlD
Xylometazoline—ADRA2C—midbrain—attention deficit hyperactivity disorder	0.000536	0.0236	CbGeAlD
Xylometazoline—HTR1B—brain—attention deficit hyperactivity disorder	0.000475	0.0209	CbGeAlD
Xylometazoline—ADRA1A—nervous system—attention deficit hyperactivity disorder	0.000463	0.0204	CbGeAlD
Xylometazoline—HTR1D—brain—attention deficit hyperactivity disorder	0.00046	0.0203	CbGeAlD
Xylometazoline—ADRA1A—central nervous system—attention deficit hyperactivity disorder	0.000445	0.0196	CbGeAlD
Xylometazoline—ADRA2C—nervous system—attention deficit hyperactivity disorder	0.000441	0.0194	CbGeAlD
Xylometazoline—ADRA1A—cerebellum—attention deficit hyperactivity disorder	0.000435	0.0192	CbGeAlD
Xylometazoline—ADRA2A—midbrain—attention deficit hyperactivity disorder	0.000428	0.0188	CbGeAlD
Xylometazoline—ADRA2C—central nervous system—attention deficit hyperactivity disorder	0.000424	0.0187	CbGeAlD
Xylometazoline—ADRA2C—cerebellum—attention deficit hyperactivity disorder	0.000415	0.0183	CbGeAlD
Xylometazoline—ADRA1A—brain—attention deficit hyperactivity disorder	0.000354	0.0156	CbGeAlD
Xylometazoline—ADRA2A—nervous system—attention deficit hyperactivity disorder	0.000352	0.0155	CbGeAlD
Xylometazoline—ADRA2A—central nervous system—attention deficit hyperactivity disorder	0.000339	0.0149	CbGeAlD
Xylometazoline—ADRA2C—brain—attention deficit hyperactivity disorder	0.000337	0.0148	CbGeAlD
Xylometazoline—ADRA2A—cerebellum—attention deficit hyperactivity disorder	0.000331	0.0146	CbGeAlD
Xylometazoline—ADRA2A—brain—attention deficit hyperactivity disorder	0.000269	0.0118	CbGeAlD
Xylometazoline—ADRA2A—GPCRs, Class A Rhodopsin-like—HTR2A—attention deficit hyperactivity disorder	3.92e-05	0.00027	CbGpPWpGaD
Xylometazoline—ADRA2A—GPCR ligand binding—DRD4—attention deficit hyperactivity disorder	3.92e-05	0.00027	CbGpPWpGaD
Xylometazoline—HTR1D—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	3.91e-05	0.000269	CbGpPWpGaD
Xylometazoline—HTR1D—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	3.9e-05	0.000268	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	3.9e-05	0.000268	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling by GPCR—ADRA2C—attention deficit hyperactivity disorder	3.88e-05	0.000267	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	3.85e-05	0.000265	CbGpPWpGaD
Xylometazoline—HTR1D—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	3.83e-05	0.000264	CbGpPWpGaD
Xylometazoline—HTR1D—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	3.83e-05	0.000264	CbGpPWpGaD
Xylometazoline—HTR1B—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	3.83e-05	0.000264	CbGpPWpGaD
Xylometazoline—ADRA2B—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	3.83e-05	0.000263	CbGpPWpGaD
Xylometazoline—HTR1B—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	3.81e-05	0.000263	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling by GPCR—DRD5—attention deficit hyperactivity disorder	3.8e-05	0.000262	CbGpPWpGaD
Xylometazoline—HTR1D—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	3.78e-05	0.00026	CbGpPWpGaD
Xylometazoline—HTR1D—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	3.76e-05	0.000259	CbGpPWpGaD
Xylometazoline—HTR1B—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	3.75e-05	0.000258	CbGpPWpGaD
Xylometazoline—HTR1B—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	3.75e-05	0.000258	CbGpPWpGaD
Xylometazoline—ADRA1D—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	3.74e-05	0.000257	CbGpPWpGaD
Xylometazoline—HTR1B—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	3.7e-05	0.000255	CbGpPWpGaD
Xylometazoline—ADRA1D—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	3.7e-05	0.000255	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	3.68e-05	0.000253	CbGpPWpGaD
Xylometazoline—HTR1B—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	3.68e-05	0.000253	CbGpPWpGaD
Xylometazoline—ADRA2A—GPCR ligand binding—DRD2—attention deficit hyperactivity disorder	3.66e-05	0.000252	CbGpPWpGaD
Xylometazoline—HTR1D—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	3.65e-05	0.000251	CbGpPWpGaD
Xylometazoline—ADRA1A—Class A/1 (Rhodopsin-like receptors)—HTR2A—attention deficit hyperactivity disorder	3.62e-05	0.000249	CbGpPWpGaD
Xylometazoline—HTR1B—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	3.58e-05	0.000246	CbGpPWpGaD
Xylometazoline—ADRA2C—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	3.57e-05	0.000246	CbGpPWpGaD
Xylometazoline—HTR1D—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	3.54e-05	0.000244	CbGpPWpGaD
Xylometazoline—HTR1D—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	3.52e-05	0.000243	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	3.52e-05	0.000242	CbGpPWpGaD
Xylometazoline—ADRA1B—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	3.52e-05	0.000242	CbGpPWpGaD
Xylometazoline—HTR1D—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	3.48e-05	0.000239	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	3.47e-05	0.000239	CbGpPWpGaD
Xylometazoline—HTR1B—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	3.46e-05	0.000238	CbGpPWpGaD
Xylometazoline—HTR1B—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	3.45e-05	0.000238	CbGpPWpGaD
Xylometazoline—ADRA1D—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	3.44e-05	0.000237	CbGpPWpGaD
Xylometazoline—HTR1D—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	3.43e-05	0.000236	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	3.42e-05	0.000235	CbGpPWpGaD
Xylometazoline—HTR1B—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	3.41e-05	0.000234	CbGpPWpGaD
Xylometazoline—ADRA2B—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	3.37e-05	0.000232	CbGpPWpGaD
Xylometazoline—HTR1B—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	3.36e-05	0.000232	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	3.36e-05	0.000232	CbGpPWpGaD
Xylometazoline—ADRA2A—Class A/1 (Rhodopsin-like receptors)—HTR2A—attention deficit hyperactivity disorder	3.36e-05	0.000231	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	3.35e-05	0.00023	CbGpPWpGaD
Xylometazoline—ADRA2B—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	3.34e-05	0.00023	CbGpPWpGaD
Xylometazoline—ADRA1D—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	3.33e-05	0.00023	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	3.29e-05	0.000226	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	3.28e-05	0.000226	CbGpPWpGaD
Xylometazoline—ADRA1D—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	3.28e-05	0.000226	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	3.24e-05	0.000223	CbGpPWpGaD
Xylometazoline—ADRA1D—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	3.24e-05	0.000223	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	3.23e-05	0.000223	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	3.22e-05	0.000221	CbGpPWpGaD
Xylometazoline—HTR1D—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	3.2e-05	0.00022	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	3.19e-05	0.00022	CbGpPWpGaD
Xylometazoline—ADRA2C—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	3.15e-05	0.000217	CbGpPWpGaD
Xylometazoline—HTR1B—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	3.13e-05	0.000216	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	3.13e-05	0.000215	CbGpPWpGaD
Xylometazoline—ADRA1A—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	3.12e-05	0.000215	CbGpPWpGaD
Xylometazoline—ADRA2C—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	3.12e-05	0.000215	CbGpPWpGaD
Xylometazoline—ADRA2B—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	3.11e-05	0.000214	CbGpPWpGaD
Xylometazoline—ADRA1B—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	3.1e-05	0.000214	CbGpPWpGaD
Xylometazoline—ADRA1B—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	3.07e-05	0.000212	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	3.04e-05	0.000209	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	3.03e-05	0.000208	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	3.02e-05	0.000208	CbGpPWpGaD
Xylometazoline—ADRA1D—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	3.02e-05	0.000208	CbGpPWpGaD
Xylometazoline—ADRA2B—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	3.01e-05	0.000207	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	2.98e-05	0.000205	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	2.96e-05	0.000204	CbGpPWpGaD
Xylometazoline—ADRA2B—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	2.96e-05	0.000204	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	2.94e-05	0.000202	CbGpPWpGaD
Xylometazoline—ADRA2B—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	2.92e-05	0.000201	CbGpPWpGaD
Xylometazoline—ADRA2C—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	2.9e-05	0.0002	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	2.9e-05	0.0002	CbGpPWpGaD
Xylometazoline—ADRA2A—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	2.9e-05	0.0002	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	2.87e-05	0.000198	CbGpPWpGaD
Xylometazoline—ADRA1B—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	2.86e-05	0.000197	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	2.84e-05	0.000195	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	2.84e-05	0.000195	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	2.82e-05	0.000194	CbGpPWpGaD
Xylometazoline—ADRA2C—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	2.81e-05	0.000194	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	2.79e-05	0.000192	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	2.78e-05	0.000191	CbGpPWpGaD
Xylometazoline—ADRA1B—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	2.77e-05	0.000191	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	2.77e-05	0.00019	CbGpPWpGaD
Xylometazoline—ADRA2C—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	2.76e-05	0.00019	CbGpPWpGaD
Xylometazoline—ADRA1A—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	2.76e-05	0.00019	CbGpPWpGaD
Xylometazoline—ADRA2A—Metabolism—ADRA2C—attention deficit hyperactivity disorder	2.74e-05	0.000189	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	2.74e-05	0.000189	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	2.73e-05	0.000188	CbGpPWpGaD
Xylometazoline—ADRA1A—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	2.73e-05	0.000188	CbGpPWpGaD
Xylometazoline—ADRA2C—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	2.73e-05	0.000188	CbGpPWpGaD
Xylometazoline—ADRA2B—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	2.72e-05	0.000187	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	2.72e-05	0.000187	CbGpPWpGaD
Xylometazoline—ADRA1B—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	2.72e-05	0.000187	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	2.71e-05	0.000187	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	2.69e-05	0.000185	CbGpPWpGaD
Xylometazoline—ADRA1B—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	2.69e-05	0.000185	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	2.67e-05	0.000184	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	2.67e-05	0.000184	CbGpPWpGaD
Xylometazoline—HTR1D—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	2.66e-05	0.000183	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	2.65e-05	0.000183	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	2.64e-05	0.000182	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	2.64e-05	0.000181	CbGpPWpGaD
Xylometazoline—HTR1B—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	2.6e-05	0.000179	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	2.59e-05	0.000179	CbGpPWpGaD
Xylometazoline—ADRA2A—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	2.56e-05	0.000176	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	2.55e-05	0.000176	CbGpPWpGaD
Xylometazoline—ADRA2C—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	2.54e-05	0.000175	CbGpPWpGaD
Xylometazoline—ADRA1A—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	2.54e-05	0.000175	CbGpPWpGaD
Xylometazoline—ADRA2A—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	2.54e-05	0.000175	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	2.51e-05	0.000173	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	2.51e-05	0.000173	CbGpPWpGaD
Xylometazoline—ADRA1B—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	2.5e-05	0.000172	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	2.48e-05	0.000171	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	2.48e-05	0.000171	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	2.47e-05	0.00017	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	2.47e-05	0.00017	CbGpPWpGaD
Xylometazoline—HTR1D—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	2.47e-05	0.00017	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	2.47e-05	0.00017	CbGpPWpGaD
Xylometazoline—ADRA1A—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	2.46e-05	0.000169	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	2.44e-05	0.000168	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	2.42e-05	0.000166	CbGpPWpGaD
Xylometazoline—ADRA1A—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	2.42e-05	0.000166	CbGpPWpGaD
Xylometazoline—HTR1B—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	2.42e-05	0.000166	CbGpPWpGaD
Xylometazoline—ADRA1A—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	2.39e-05	0.000164	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	2.37e-05	0.000163	CbGpPWpGaD
Xylometazoline—ADRA2A—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	2.36e-05	0.000162	CbGpPWpGaD
Xylometazoline—ADRA2C—Metabolism—TPH2—attention deficit hyperactivity disorder	2.33e-05	0.00016	CbGpPWpGaD
Xylometazoline—ADRA2C—Metabolism—CACNB2—attention deficit hyperactivity disorder	2.33e-05	0.00016	CbGpPWpGaD
Xylometazoline—HTR1D—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	2.32e-05	0.00016	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	2.31e-05	0.000159	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	2.3e-05	0.000159	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	2.3e-05	0.000159	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	2.29e-05	0.000158	CbGpPWpGaD
Xylometazoline—ADRA2C—Metabolism—DPYD—attention deficit hyperactivity disorder	2.29e-05	0.000158	CbGpPWpGaD
Xylometazoline—ADRA2A—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	2.28e-05	0.000157	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	2.27e-05	0.000156	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	2.27e-05	0.000156	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	2.25e-05	0.000155	CbGpPWpGaD
Xylometazoline—HTR1D—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	2.24e-05	0.000154	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	2.23e-05	0.000154	CbGpPWpGaD
Xylometazoline—ADRA1A—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	2.22e-05	0.000153	CbGpPWpGaD
Xylometazoline—ADRA2A—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	2.22e-05	0.000153	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	2.2e-05	0.000152	CbGpPWpGaD
Xylometazoline—HTR1B—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	2.19e-05	0.000151	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	2.19e-05	0.000151	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	2.17e-05	0.000149	CbGpPWpGaD
Xylometazoline—HTR1D—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	2.16e-05	0.000149	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	2.14e-05	0.000147	CbGpPWpGaD
Xylometazoline—ADRA2C—Metabolism—CACNA1C—attention deficit hyperactivity disorder	2.13e-05	0.000147	CbGpPWpGaD
Xylometazoline—HTR1B—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	2.11e-05	0.000145	CbGpPWpGaD
Xylometazoline—ADRA1D—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	2.11e-05	0.000145	CbGpPWpGaD
Xylometazoline—HTR1D—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	2.09e-05	0.000144	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	2.07e-05	0.000143	CbGpPWpGaD
Xylometazoline—ADRA2A—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	2.07e-05	0.000142	CbGpPWpGaD
Xylometazoline—HTR1D—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	2.05e-05	0.000141	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	2.05e-05	0.000141	CbGpPWpGaD
Xylometazoline—HTR1B—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	2.05e-05	0.000141	CbGpPWpGaD
Xylometazoline—HTR1D—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	2.03e-05	0.00014	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	2.02e-05	0.000139	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	2.01e-05	0.000139	CbGpPWpGaD
Xylometazoline—HTR1B—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	2.01e-05	0.000138	CbGpPWpGaD
Xylometazoline—HTR1B—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	1.99e-05	0.000137	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	1.99e-05	0.000137	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	1.92e-05	0.000132	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	1.92e-05	0.000132	CbGpPWpGaD
Xylometazoline—ADRA2B—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	1.91e-05	0.000131	CbGpPWpGaD
Xylometazoline—ADRA2A—Metabolism—TPH2—attention deficit hyperactivity disorder	1.89e-05	0.00013	CbGpPWpGaD
Xylometazoline—ADRA2A—Metabolism—CACNB2—attention deficit hyperactivity disorder	1.89e-05	0.00013	CbGpPWpGaD
Xylometazoline—HTR1D—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	1.89e-05	0.00013	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	1.89e-05	0.00013	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	1.88e-05	0.000129	CbGpPWpGaD
Xylometazoline—ADRA2C—Metabolism—SNAP25—attention deficit hyperactivity disorder	1.86e-05	0.000128	CbGpPWpGaD
Xylometazoline—ADRA2A—Metabolism—DPYD—attention deficit hyperactivity disorder	1.86e-05	0.000128	CbGpPWpGaD
Xylometazoline—HTR1B—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	1.85e-05	0.000127	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	1.85e-05	0.000127	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	1.79e-05	0.000123	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	1.79e-05	0.000123	CbGpPWpGaD
Xylometazoline—ADRA2C—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	1.78e-05	0.000123	CbGpPWpGaD
Xylometazoline—ADRA2C—Metabolism—ADRA2A—attention deficit hyperactivity disorder	1.77e-05	0.000122	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	1.76e-05	0.000121	CbGpPWpGaD
Xylometazoline—ADRA1B—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	1.75e-05	0.000121	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	1.74e-05	0.00012	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	1.73e-05	0.000119	CbGpPWpGaD
Xylometazoline—ADRA2A—Metabolism—CACNA1C—attention deficit hyperactivity disorder	1.73e-05	0.000119	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	1.68e-05	0.000115	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	1.68e-05	0.000115	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	1.67e-05	0.000115	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	1.65e-05	0.000114	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	1.62e-05	0.000111	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	1.62e-05	0.000111	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	1.61e-05	0.000111	CbGpPWpGaD
Xylometazoline—ADRA2B—Hemostasis—EP300—attention deficit hyperactivity disorder	1.6e-05	0.00011	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	1.59e-05	0.00011	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	1.59e-05	0.000109	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	1.57e-05	0.000108	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	1.56e-05	0.000107	CbGpPWpGaD
Xylometazoline—ADRA1A—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	1.56e-05	0.000107	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	1.56e-05	0.000107	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	1.53e-05	0.000106	CbGpPWpGaD
Xylometazoline—ADRA2A—Metabolism—SNAP25—attention deficit hyperactivity disorder	1.51e-05	0.000104	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	1.51e-05	0.000104	CbGpPWpGaD
Xylometazoline—ADRA2C—Hemostasis—EP300—attention deficit hyperactivity disorder	1.49e-05	0.000103	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	1.48e-05	0.000102	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	1.48e-05	0.000102	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	1.46e-05	0.000101	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	1.46e-05	0.000101	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	1.46e-05	0.000101	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	1.46e-05	0.0001	CbGpPWpGaD
Xylometazoline—ADRA2A—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	1.45e-05	9.96e-05	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	1.44e-05	9.92e-05	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	1.41e-05	9.73e-05	CbGpPWpGaD
Xylometazoline—ADRA2C—Metabolism—COMT—attention deficit hyperactivity disorder	1.41e-05	9.72e-05	CbGpPWpGaD
Xylometazoline—ADRA2C—Metabolism—MAOA—attention deficit hyperactivity disorder	1.4e-05	9.65e-05	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	1.36e-05	9.39e-05	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	1.36e-05	9.37e-05	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	1.36e-05	9.37e-05	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	1.34e-05	9.24e-05	CbGpPWpGaD
Xylometazoline—HTR1D—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	1.32e-05	9.11e-05	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	1.32e-05	9.08e-05	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	1.31e-05	9.04e-05	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	1.3e-05	8.92e-05	CbGpPWpGaD
Xylometazoline—HTR1B—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	1.3e-05	8.92e-05	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	1.28e-05	8.81e-05	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	1.27e-05	8.71e-05	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	1.23e-05	8.44e-05	CbGpPWpGaD
Xylometazoline—ADRA2A—Hemostasis—EP300—attention deficit hyperactivity disorder	1.21e-05	8.35e-05	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	1.19e-05	8.21e-05	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	1.19e-05	8.19e-05	CbGpPWpGaD
Xylometazoline—ADRA2A—Metabolism—COMT—attention deficit hyperactivity disorder	1.15e-05	7.89e-05	CbGpPWpGaD
Xylometazoline—ADRA2A—Metabolism—MAOA—attention deficit hyperactivity disorder	1.14e-05	7.84e-05	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	1.13e-05	7.8e-05	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	1.11e-05	7.63e-05	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	1.02e-05	7.04e-05	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	9.55e-06	6.58e-05	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	9.4e-06	6.47e-05	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	8.35e-06	5.75e-05	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	7.76e-06	5.34e-05	CbGpPWpGaD
Xylometazoline—HTR1D—Signaling Pathways—EP300—attention deficit hyperactivity disorder	7.01e-06	4.83e-05	CbGpPWpGaD
Xylometazoline—HTR1B—Signaling Pathways—EP300—attention deficit hyperactivity disorder	6.87e-06	4.73e-05	CbGpPWpGaD
Xylometazoline—ADRA2C—Metabolism—EP300—attention deficit hyperactivity disorder	6.05e-06	4.17e-05	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling Pathways—EP300—attention deficit hyperactivity disorder	6e-06	4.13e-05	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling Pathways—EP300—attention deficit hyperactivity disorder	5.42e-06	3.73e-05	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—EP300—attention deficit hyperactivity disorder	5.06e-06	3.48e-05	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—EP300—attention deficit hyperactivity disorder	4.98e-06	3.43e-05	CbGpPWpGaD
Xylometazoline—ADRA2A—Metabolism—EP300—attention deficit hyperactivity disorder	4.92e-06	3.39e-05	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—EP300—attention deficit hyperactivity disorder	4.43e-06	3.05e-05	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—EP300—attention deficit hyperactivity disorder	4.11e-06	2.83e-05	CbGpPWpGaD
